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Abstract
Genetic association studies are now routinely used to identify single nucleotide polymorphisms (SNPs) linked with human
diseases or traits through single SNP-single trait tests. Here we introduced partial least squares path modeling (PLSPM) for
association between single or multiple SNPs and a latent trait that can involve single or multiple correlated measurement(s).
Furthermore, the framework naturally provides estimators of polygenic effect by appropriately weighting trait-attributing
alleles. We conducted computer simulations to assess the performance via multiple SNPs and human obesity-related traits
as measured by body mass index (BMI), waist and hip circumferences. Our results showed that the associate statistics had
type I error rates close to nominal level and were powerful for a range of effect and sample sizes. When applied to 12
candidate regions in data (N=2,417) from the European Prospective Investigation of Cancer (EPIC)-Norfolk study, a region in
FTO was found to have stronger association (rs7204609,rs9939881 at the first intron P=4.29610
27) than single SNP
analysis (all with P.10
24) and a latent quantitative phenotype was obtained using a subset sample of EPIC-Norfolk
(N=12,559). We believe our method is appropriate for assessment of regional association and polygenic effect on a single
or multiple traits.
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Introduction
Current genetic association studies in humans, including
genome-wide association studies (GWASs) [1], typically involve
association of individual SNPs with a trait of interest. Notable
drawbacks [2] of such an approach include multiple testing and
inability to account for the correlation among SNPs in a region or
treat genes as a functional unit [3]. Many attempts were made to
account for correlations among SNPs, such as haplotype analysis
[4], p-value or odds ratio combination [5–7], principal component
analysis (PCA) [8], cluster [9], canonical correlation [10], data
mining [11–14], and scan (or slide-windows) statistics [14–16].
Regardless the extent to which these approaches have succeeded,
they are not developed for integrating multiple related traits
underlying a condition or disease. For instance, type II diabetes is
linked with fasting glucose, HbA1C, and glucose tolerance, among
others; and obesity is another with body mass index (BMI), waist
and hip circumference. Ideally, liabilities for developing diseases
should be measured on quantitative dimensions [17] with available
measurements [17,18], so as to gain more statistical power and
facilitate derivation of clinically relevant features [17,19]. The case
to combine multiple variants and multiple measurements is
compelling and in line with the fact that an increasing number of
trait-associated SNPs are identified with the challenge to implement
an appropriate weighting scheme for the trait-attributing alleles.
We set to exploit association between multiple SNPs and
multiple traits through a latent variable partial least squares path
modeling (PLSPM) [20,21] in a context analogous to GWAS: for
the discovery sample a set of genetic variants and a latent
quantitative trait are modeled through scan statistics and for the
replication sample small effects of SNPs from different genes (or
genomic regions) are aggregated through polygenic statistics. We
examined the performance of the scan statistics with respect to
type I error rate and statistical power through computer
simulations. Our methods were then applied to 12 regions of
GWAS data [22,23] from the European Prospective Investigation
of Cancer (EPIC)-Norfolk study.
Methods
Study samples
Participants in the EPIC-Norfolk study were men and women
aged between 45 and 74 from Norwich and the surrounding towns
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e31927and rural areas [24,25]. In 2006, a case-cohort study was
conducted in which 3,867 individuals were assayed with
Affymetrix 500 K genechips among whom subcohort (N=2,566)
was a random sample of the study cohort at baseline and cases
were part of the remaining individuals with BMI$30 kg/m
2
(N=1,301). A total of 2,417 individuals in the subcohort and 1,135
cases with 446,861 SNPs passed quality control and in silico
genotypes were obtained according to HapMap (http://www.
hapmap.org) [22,23]. An additional sample of 12,559 individuals
had complete data on age, sex, BMI, waist and hip circumferences
along with 12 BMI associated SNPs in or near genes NEGR1
(rs3101336), SEC16B (rs10913469), TMEM18 (rs6548238), ETV15
(rs7647305), GNPDA2 (rs10938397), BDNF (rs925646), MTCH2
(rs10838738), SH2B1 (rs7498665), FAIM2 (rs7132908), FTO
(rs1121980), MC4R (rs17782313), and KCTD15 (rs369784).
Anthropometric measurements
The influence of body fat distribution has been linked with body
shape named crudely after the fruits and vegetable(s) they resemble
most [26,27]. Studies have shown that people with a larger waist
have higher risks of hypertension, type 2 diabetes and high
cholesterol than those who carry excess weight on the hips [28,29].
The combination of BMI, waist and hip circumferences is also a
good predictor of cardiovascular risk and mortality [26,29–32]. In
this paper, nine types of body shape have been derived from the
combination (Table S1) and supported by significant differences in
these anthropometric traits by types and sexes. As will soon
become clear, adoption of this combination as an approximate
quantification of ‘‘body shape’’ is furnished through a latent score
from formal statistical modelling. Note that the derivation differs
from other possible definitions, e.g., http://en.wikipedia.org/
wiki/Body_shape.
The modeling framework
As hinted earlier, our framework resembles structural equation
modeling (SEM) with three types of parameters defined: (1) Latent
variable scores (j) as combinations of their manifest variables
obtained iteratively from an ordinary least squares (OLS)-type
algorithm; (2) path coefficients (b’s) between dependent (j2) and
independent latent variable (j1) by OLS or partial least squares
(PLS); (3) loadings (l’s) of each block of manifest variables with its
latent variables by OLS. In this paper, the Lohma ¨ller PLSPM
algorithm was used [24,26]. The relations between these
parameters are shown in Figure 1 and used in two contexts: (1a)
scan statistics are used for the detection of the genomic region (j1)
– body shape (j2) association in initial data analysis; (1b) the
polygenic effect of a set of SNPs (j1) on body shape (j2) is obtained
with the replication sample. More information about SEM and
PLSPM is available as Information S1.
Non-parametric bootstrap
As the distribution of parameters from PLS is unknown,
significant test of path coefficients and loadings were furnished by
Figure 1. PLSPM-based models. (a) Scan statistic model, where j1 represents genomic region containing P SNPs and b21 the regional effect on the
body shape score j1;( b) Polygenic effect model, where j’1 represents polygenic risk score and b’21 the polygenic effect. In both models, l’s are the
loadings while b’s are the path coefficients.
doi:10.1371/journal.pone.0031927.g001
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bootstrap samples (5,000), each with the same number of cases as
the original sample, were generated. Parameter estimation was
done for each bootstrap sample, whose path coefficients or
loadings can be viewed as an approximation of the sampling
distribution. All bootstrap samples together provided estimators
for mean and standard error of each parameter. Significance of a
parameter (w) under the null hypothesis: H0:w~0 and the
alternative HA:w=0 was tested via a normal test in the form
U~
w{0 jj
se(w)
(e.g., U~
b21{0 jj
se(b21)
) where se(w) is the bootstrapped
standard error [20,21].
Interpretation
Let bij =the path coefficient between the i-th and the j-th latent
variable and lij =loading between the i-th manifest variable and the
j-th latent variable. The interpretation can then be facilitated
according to Figure 1: (1) path coefficient (b21) in the structure
(inner) model represents an overall effect of the genome region or
polygenic effect of a SNPs set (j1) on body shape (j2); (2) R2 is the
proportion of variance explained; (3) With path coefficients and
loading obtained from the standardized variables, their product in a
given path is a measure of the effect of a specific SNP on a single
trait or body shape (j2). For example, the effect of SNP2 on body
shape (j2)i sl21:b21, and that on BMI is l21:b21:l32; (4) Body shape
score (BSS), as a combination of waist, hip and BMI with weights
l12, l22, and l32, represents a latent quantitative phenotype of body
shape such that wais^ t t~wais  t tzl12swaist:j2, hi^ p p~hi  p pzl22ship:j2,
BM^ I I~BM  I Izl32sBMI:j2 with the body type determined by
(BM  I Izl32sBMI) and (WH^ R R~(wais  t tzl12swaist)=(hi  p pzl22ship)
according to their thresholds (Table S1), and (5) the latent polygenic
liability (j1) aggregated by small effects of DNA variants in different
genome regions with their weights l11, l21,… ,lp1 is the polygenic
risk score (PRS) of the SNP set (Figure 1b).
Simulation
Simulations were conducted as follows: (1) HapMap phase II CEU
data at the brain-derived neurotrophic factor (BDNF) region (Chr
11:27633610..27692970 with 24 SNPs) were used to generate the
simulated genotypic data; (2) Based on (1), a large sample of 500,000
individuals was obtained via software gs 2.0 [35] with the 6
th SNP
being the causal variant; (3) Quantitative genetic data was generated
according to a trivariate normal distribution X~N(m,S),w h e r e
X~ x1,x2,x3 ðÞ is the random vector (waist, hip, BMI) for ‘‘apple-
shaped’’ types (N=355) in EPIC-Norfolk GWAS subcohort with
their sample mean X~(105:2746,106:0051, 29:2172) and covari-
ance S~
52:1991 36:8688 16:9545
36:8688 37:1419 13:7969
16:9545 13:7969 8:3859
0
@
1
A
. Assume that the causal
SNP had no effect on body shape (H0), m~
(105:2746,106:0051, 29:2172) for all three genotypes (GG, GA,
and AA) and that the causal SNP effects on waist not on hip, and the
single allele effect size on BMI is d kg/m
2 (H1), m~
(105:2746,106:0051, 29:2172zid),w h e r ei=0,1,2 for GG, GA
and AA, respectively. The range of d~ (0.10, 0.15, 0.20, 0.25, 0.30)
was estimated by published data on genetic predisposition score [18].
Given the increment d on BMI, estimation of waist under fixed hip
was obtained by wais^ t t~10:20345z0:62138:hipz0:99947:BMI
(F~568:25,Pv0:0001,R2~0:7635) established by the same
‘‘apple-shaped’’ data in the EPIC-Norfolk GWAS; (4) Genotypic
data were simulated under various sample sizes from the simulated
CEU population (500,000 individuals), and quantitative genetics
models with the given d were created by the R mvtnorm package.
T h ew i n d o ws i z eh a d1 0S N P sf r o mt h e3
th to the 12
th SNP. Under
H0, 10,000 simulations given various sample sizes were conducted to
assess the type I error. Under H1, for each model and a given d,
10,000 simulations were conducted under various sample sizes to
assess power. The procedures were implemented with Linux and the
R plspm package. Both mvtnorm and plspm packages are
available from CRAN. (http://cran.r-project.org/)
Analysis of the EPIC-Norfolk data
Scan statistics were built through the subcohort for association
between the 12 regions and body shape, and to contrast with a
SNP-wise single trait test performed by linear regressions
(waist~b0zb1SNPizei, hip~b0zb1SNPizei, BMI~b0z
b1SNPizei) according to sizes of sliding windows of 1 to 15 SNPs,
and the a-level was defined as 1|10{5 accordingto theliterature [4]
for region-based analysis. Polygenic effects on single or latent traits
with the PLSPM polygenic statistics were obtained and compared
with unweighted sum of BMI-increasing alleles [18] and we also
assessed whether j2 is an appropriate latent quantitative measure-
ment.
Results
Simulation
As shown in Figure 2, the type I error rates of the scan statistics
were close to nominal levels (0.01, 0.05) as a function of sample
sizes (2a, 2b). Power monotonically increases with sample size,
effect size (d), or nominal level (a) (2c–2f). Even with a very small a,
for effect size greater than 0.15 and the sample size of up to 4,500,
the scan statistics remained to have .80% power (2e, 2f).
Analysis of the EPIC Norfolk data
Single trait results. The model provided the usual
association results for single trait adjusted for sex and age
including effect size estimate, proportion of variance explained
and statistical significance. Results on BMI, waist and hip
circumferences were also similar for PRS. Shown in Figure S1
and Table S2 are SEM and results of the 12 SNPs in the 12 gene
regions adjusted for sex and age for single trait (a1,b1,c1) as with
distribution of their PRS and cumulative effects of these variants
(a2,b2 c2). More details can be found in Information S2.
Multi-trait results. As shown in Figure 3, none of the SNPs
were significant at 10
24 level according to single-SNP –single-trait
tests nor according to sliding window sizes of 1–4 SNPs at the 10
25
level, but smaller p values were obtained for window sizes of 5–11
and 12–15 SNPs. Of particular interest was rs720-
4609,rs9939881 at the first intron of FTO with b21~{0:091,
P=4.29610
27 for a sliding window of size 10; its model structure
is shown in Figure 4. The standardized overall effect (95% CI) of
the genome region on body shape was 20.100 (2014- 20.08)
without adjustment for sex and age, and 20.09 (20.13- 20.07)
with adjustment. The effect (95%CI) of a specific SNP on body
shape or on a single trait are available 20.09 (20.08- 20.08) and
0.07 (20.06- 20.05) after adjusting for sex and age, respectively
for rs58044769. These results suggest that the location of the
causal variant in the 10-SNP loading vector is likely between the
rs58044769 and rs11642841 (the sixth SNP).
Figure 5a and Table 1 show models and results of the 12 SNPs
in the 12 gene regions adjusted for sex and age, where the
standardized effect (lSNP?b21) (95%CI) per allele on body shape
was 0.08 (0.07–0.10, P=7.91610
224). The proportion of variance
explained was 0.8% by PRS. All genetic variants showed
associations with body shape, though some loadings of the SNPs
were not significant at a=0.05 (Table 1). There were substantial
LVPLSPM for Association and Ploygenic Effect
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being rs1121980 (FTO) and rs925646 (BDNF) for all the four traits,
followed by rs6538238 (TMEM18), rs17782313 (MC4R) for BMI
and hip; rs17782313 (MC4R), rs7132908 (FAIM2) for waist and
body shape. Non-standardized effect sizes were largest with
rs1121980 (FTO) (0.39), but smallest with rs7647305 (ETV5)
(0.05) (see also Figures 5 and S1).
Shown in Figure 5b is the distribution of PRS and cumulative
effects of these variants, from which we made the following
observations: (1) PRS was normally distributed, with ranges of
0.05–1.69 for body shape, with the majority (68.27%) of
individuals (  X X+S) also showing similar patterns of PRS
(0.8660.21); (2) for each level of PRS the distribution of body
shape had similar pattern according to boxplots, generally
normally distributed with range 0.4–1.3 for PRS but skewed with
,0.4 or .1.3; (3) The means of body shape score increased
linearly with PRS, with on average each additional unit associated
with increments (P) of 2.28 (7.91610
224).
Shown in Table 2 and Figure 6 are the distribution of body shape
types and characteristics of body shape score in the EPIC-Norfolk
replication samples, from which several observations can be made.
(1) types (men%, women%) were predominantly 1 (29.30%,
33.87%), 4 (31.58%, 19.35%) and 5 (16.55%, 11.61%). There
was significant sex difference of overall body shape types
(x
2=1556.8, P,.0001), especially in types 4, 5, 6, 9, 2, 3; (2) for
both men and women, along with the risk of obesity, body shape
score was seen to be monotonically increasing from types 1 to 9
(Table 2 and Figures 6c, 6d), with significant differences between
given two types (F=1994.80, P,0.0001 for men, F=2468.78,
P,0.0001 for women, both with p,0.05 according to SNK test).
Figure 2. Simulation results of type I error and power for scan statistic model.
doi:10.1371/journal.pone.0031927.g002
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(F=15214.2, P,0.0001, R
2=0.71) and women (F=17574.2,
P,0.0001, R
2=0.74) (Figures 6c, 6d), suggesting body shape score
is an excellent measure; (3) BSS follows an approximate normal
distribution (see Figure S2); (4) The estimated BMIs and waist-hip
ratios (WHRs) were 29.52 and 0.97 for men, 30.25 and 0.83 for
women,respectively.Polygeniceffectsofthe 12SNPscontributed to
type 5 on the basis of the nine (Table S1) in both men and women.
Discussion
A latent variable PLSPM framework is outlined for association
of multiple SNPs with multiple traits, the behavior of such an
association was investigated by simulation study through type I
error rate and power. Meanwhile, a polygenic statistic was
developed for quantification of a polygenic effect by appropriately
weighting trait-attributing alleles. These methods were applied to
the study of obesity-related variables in the EPIC-Norfolk study for
which a latent score was obtained. Below we compare these with
available methods, discuss implications of our findings as with
other issues involved and indicate some further work.
Compared to SEM, PLSPM is robust to multicollinearity
commonly encountered in GWAS data (such as strong linkage
disequilibrium between SNPs and high correlation between traits). It
is a ‘‘soft modelling’’ approach requiring very few distributional
assumptions, variables can be numerical, ordinal or nominal, and no
need for normality assumptions, while covariance-based SEM is a
‘‘hard modeling’’ with heavy distributional assumptions [20,21].
Through simulation, thescan statistics gave agoodapproximationof
the type I error rate and proved powerful for novel region-based
latentquantitativetraits analysis, evenwith veryhigh significantlevel
and a modest single SNP effect size. Our result also agreed with the
Figure 3. Manhattan plot for single and multiple traits in the 12 gene regions.
doi:10.1371/journal.pone.0031927.g003
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covariates.
doi:10.1371/journal.pone.0031927.g004
Figure 5. Fitted model for the 12 SNPs from the 12 gene regions with adjustment for sex and age for multiple traits (a) as with
distribution of its PRS and cumulative effects of these variants (b).
doi:10.1371/journal.pone.0031927.g005
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scan statistics are embedded with the ‘‘thinking quantitatively
framework’’ [17] such that there is a theoretical quantitative trait for
each qualitative trait and normally distributed polygenic liabilities.
Their advantages are as follows: First, it can capture the association
between a genomic region and a latent quantitative phenotype of
disorder (or trait) all in continuous quantitative dimensions. Second,
the model structure provides abundant information for interpreta-
tion. Third, fine region of the causal SNP can be located by the
loading vector of SNPs in the window (the potential causal variant is
probably located between rs58044769 and rs11642841). The latent
score of obesity-related variables is a synthetic quantitative
phenotype which effectively combines waist, hip and BMI to reflect
the risk of obesity in accordance with increasing WHR given
increasing BMI. Its derivation is a motivating example for many
other disorders and traits, such as diabetes, heart disease and
metabolic syndrome.
Analysis of the EPIC-Norfolk discovery sample involving 12 gene
regions suggested that the scan statistics are more powerful than
single SNP – single trait tests with the size 10 providing the strongest
evidence. In particular, the region (rs7204609,rs9939811) within
the first intron 1 of FTO gene is of interest, as with some of the
reported obesity-susceptibility SNPsnear orinthe 12genes [18].We
would like to highlight the utility of PRS. It refers to a set of DNA
variants in different genome regions associated with a trait, termed
previously as polygenic susceptibility score [36], genomic profiles
[37], SNP set [38], aggregate risk scores [39] or genetic
predisposition score [18]. Their apparent drawback is the lack of
an appropriate scheme for weighting. PRS not only weights the
individual risk alleles by the loading vector of the SNP set but also
Table 1. Loadings, p values, indirect and overall effects of 12 SNPs, PRS on body shape with adjustment for sex and age.
SNP/PRS or measurements Gene Body shape (b21=0.0816, P=7.91610
224)
Loading (l) P value Indirect effect (l?b21) Overall effect
rs3101336 NEGR1 0.1939 0.0635 0.0158 0.1362
rs10913469 SEC16B 0.2386 0.0198 0.0195 0.2033
rs6548238 TMEM18 0.2097 0.0406 0.0171 0.1892
rs7647305 ETV5 0.0622 0.5452 0.0051 0.0515
rs10938397 GNPDA2 0.2217 0.0309 0.0181 0.1513
rs925946 BDNF 0.4080 1.07E-05 0.0333 0.3004
rs10838738 MTCH2 0.0987 0.3221 0.0081 0.0699
rs7132908 FAIM2 0.3305 0.0017 0.0270 0.2302
rs7498665 SH2B1 0.1684 0.1084 0.0137 0.1168
rs1121980 FTO 0.5714 1.08E-10 0.0466 0.3908
rs17782313 MC4R 0.3466 0.0005 0.0283 0.2788
rs368794 KCTD15 0.2117 0.0352 0.0173 0.1538
PRS 7.91E-24 0.0816 2.2798
waist 0.9817 0.00E+00
Hip 0.7525 0.00E+00
BMI 0.8443 0.00E+00
doi:10.1371/journal.pone.0031927.t001
Table 2. Distribution of body shape types and characteristics of body shape score (BSS) by sex in the EPIC-Norfolk study.
Body shape types Symbol Men (F=1916.50, P,0.0001) Women (F=2457.32, P,0.0001)
n % Mean ± SD 95% CI n % Mean ± SD 95% CI
Chilli A( 1 ) 1825 29.30 55.2562.57 (55.13,55.37) 2144 33.87 51.5762.69 (51.47,51.68)
Chilli pear-apple B( 2 ) 196 3.15 57.1362.11 (56.83,57.43) 455 7.19 53.1762.58 (52.93,53.41)
Chilli apple C( 3 ) 46 0.74 57.4562.21 (56.82,58.08) 209 3.30 54.3362.51 (53.99,54.67)
Pear D( 4 ) 1967 31.58 60.3162.31 (60.21,60.41) 1225 19.35 57.6962.56 (57.55,57.83)
Pear-apple E( 5 ) 1037 16.65 61.8762.31 (61.73,62.01) 735 11.61 58.8862.51 (58.70,59.06)
Apple F( 6 ) 348 5.59 62.6062.66 (62.32,62.88) 552 8.72 60.1662.67 (59.94,60.38)
Big pear G( 7 ) 210 3.37 67.4163.94 (66.87,67.94) 288 4.55 66.4665.37 (65.84,67.08)
Big pear-apple H( 8 ) 334 5.36 68.4363.65 (68.04,68.82) 325 5.13 67.6765.13 (67.11,68.23)
Big apple I( 9 ) 266 4.27 69.5064.19 (69.00,70.00) 397 6.27 69.3165.50 (68.77,69.85)
Total 6229 100.00 60.1664.94 (60.04,60.28) 6330 100.00 57.1766.51 (57.01,57.33)
doi:10.1371/journal.pone.0031927.t002
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phenotype (BSS). Our data showed that PRS was normally
distributed, which is consistent with the notion that a theoretical
quantitative trait correspond to normally distributed polygenic
liabilities (see Figure 5b, Figure S1-(a2,b2,c2)) [17]. Unlike the
unweighted estimator, it is also coherent and accurate. For instance,
total effects of PRS or a specific SNP on the single trait (BMI, waist
or hip circumferences) and on the latent quantitative phenotype
(body shape) can be compared by the standardized path coefficient
or the product of loading and path coefficients along the path,
respectively. The non-standardized path coefficient or the productof
loading and path coefficients, total effects of a specific SNP on a
single trait and on the latent quantitative phenotype can also be
obtained. The mean BMI, waist circumference, hip circumference
and body shape score increased in a linear fashion as the PRS
increases. The effect of PRS on body shape type can be derived.
A reviewer has indicated previous work on multiple linked
quantitative trait loci (QTLs) [40,41] that bear some spirit to our
use of multiple SNPs. Together with the academic editor they have
expressed concerns over the possible impact of population
stratification. Fortunately, with availability of genomic data such
a concern can be relieved with multiple markers directly [42] or
via summary statistics from principal components analysis [43].
The EPIC-Norfolk GWAS has contributed to a variety of
consortia, for which the inflation factor derived from per SNP
association statistics is always close to one. This is likely to be the
result of both homogenous sample and exclusion of outliers at the
quality control stage. We believe the analysis as conducted in this
Figure 6. SEM of body shape score in the EPIC-Norfolk replication samples (a,b), the linear regression between BSS and body shape
types (c,d).
doi:10.1371/journal.pone.0031927.g006
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necessary to include summary statistics such as principal
components as covariates in the model.
A reviewer has questioned the adequacy of body shape as with
PLS with a view that body share should be supported by various
other measurements such as limb lengths, shoulder widths, etc.
However,ourinterestliesmoreinutilizingtheanthropometrictraits
from a population study for investigation of health risks. Indeed our
results showed that BSS is approximately normal (Figure S2) and
serves as an excellent measurement of body shape types (Figures 6c,
6d). The use of latent trait is also consistent with Fisher’s derivation
of polygenic effect [17]. At the time the paper was submitted for
publication, a form of PLS has appeared for multiple markers [44].
There will be several lines of further research. Firstly, there is an
important need to examine the precise nature of regional or
polygenic effect on a single trait or a collection of traits, as it may
involve both polygenic and pleiotropic effects. This is also the case
with GWAS. Long before this work when we reported work using
SEM to differentiate pleiotropic effect on obesity-related traits in a
GIANT consortium (http://www.broadinstitute.org/collaboration/
giant/index.php/Main_Page) teleconference, a colleague instantly
questioned the feasibility across the whole consortium. Secondly, the
scan statistics seemed slightly anticonservative and a parametric
counterpart is preferable. Thirdly, it will be desirable to catch both
linear and nonlinear effects between genome region and latent
quantitative trait.
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